Whereas most studies have linked HLA-G expression with tumor immune evasion due to its interaction with inhibitory receptors on immune cells5, 8–10, other reports suggest that HLA-G can activate NK cells and promote cytotoxicity because of its interaction with the KIR2DL4 receptor11, 12. This evidence concerns the gene KIR2DL4 and neoplasm.